Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges.
Saved in:
| Title: | Preclinical screening models in anticancer drug development: strengths, limitations, and translational challenges. |
|---|---|
| Authors: | Yadav R; Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Singh S; Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Kumar S; Department of Pharmaceutics, Chitkara College of Pharmacy, Chitkara University, Rajpura, India., Kolay A; Department of Pharmaceutics, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Sharma H; Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Dorai R; Department of Pharmaceutical Chemistry, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Sharma AK; Department of Pharmacology, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Singh RP; Department of Pharmaceutics, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India., Yadav MK; Department of Pharmaceutical Chemistry, Nims Institute of Pharmacy, Nims University Rajasthan, Jaipur, India. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 11; Vol. 17, pp. 1822764. Date of Electronic Publication: 2026 May 11 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1822764 |
